SYNDAX PHARMACEUTICALS INC

Ticker: SNDX CUSIP: 87164F105 Class: Common Stock

OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AM's Holding History (CIK: 0001132716)

Note: Option positions (PUT/CALL) are excluded.

Q2 2025

Shares 90,441 Value ($000) $847 Avg Close $11.01 Range $8.58 - $14.24

Q1 2025

Shares 59,438 Value ($000) $730 Avg Close $14.10 Range $12.06 - $16.95

Q4 2024

Shares 90,232 Value ($000) $1,193 Avg Close $17.11 Range $12.40 - $22.50

Q3 2024

Shares 89,481 Value ($000) $1,723 Avg Close $20.66 Range $17.34 - $25.07

Q2 2024

Shares 110,454 Value ($000) $2,268 Avg Close $20.93 Range $18.65 - $24.38

Q1 2024

Shares 108,431 Value ($000) $2,581 Avg Close $22.30 Range $19.58 - $25.34

Q4 2023

Shares 95,949 Value ($000) $2,073 Avg Close $15.37 Range $11.21 - $21.84

Period	Shares	Value ($000)	Average Close	Price Range
Q2 2025	90,441	$847	$11.01	$8.58 - $14.24
Q1 2025	59,438	$730	$14.10	$12.06 - $16.95
Q4 2024	90,232	$1,193	$17.11	$12.40 - $22.50
Q3 2024	89,481	$1,723	$20.66	$17.34 - $25.07
Q2 2024	110,454	$2,268	$20.93	$18.65 - $24.38
Q1 2024	108,431	$2,581	$22.30	$19.58 - $25.34
Q4 2023	95,949	$2,073	$15.37	$11.21 - $21.84